Abstract

Meeting abstracts Adoptive cell transfer (ACT) of tumor specific T lymphocytes, after host immunodepletion, was shown to mediate objective cancer regression of metastatic melanoma. Effective T cell activation depends, among other factors, on the functional avidity of the peptide-MHC complex (pMHC)

Highlights

  • Adoptive cell transfer (ACT) of tumor specific T lymphocytes, after host immunodepletion, was shown to mediate objective cancer regression of metastatic melanoma

  • Unlike antibodies whose affinities improve over time by somatic hypermutation (SHM), T cell receptor (TCR) do not undergo SHM

  • In our research we developed a system that can increase the affinity of a TCR to its ligand by subjecting TCR genes to somatic hypermutation, directed by the mutator enzyme Activation Induced cytidine Deaminase (AID)

Read more

Summary

Introduction

Adoptive cell transfer (ACT) of tumor specific T lymphocytes, after host immunodepletion, was shown to mediate objective cancer regression of metastatic melanoma. Gozlan et al Journal for ImmunoTherapy of Cancer 2013, 1(Suppl 1):P11 http://www.immunotherapyofcancer.org/content/1/S1/P11 “First AID” for T cell adoptive transfer: TCR affinity maturation by somatic hypermutation Yosi M Gozlan*, Esther Tzehoval, Lea Eisenbach

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.